InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by KIM PETER S, Director. Director active across 1 companies, notably Entrada Therapeutics, Inc.. In total, 2 disclosures have been logged. Total volume traded: €680k. The latest transaction was disclosed on 13 May 2024 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
US$340,02725,000 shares@ US$13.60110.14% mcap100.0% of flow
Common Stock
SEC:0001689375-25-000035·
Ideal exit: 7 Feb 2025 (T+270)
€340,02725,000 shares@ €13.60110.14% mcap50.0% of flow
Common Stock
SEC:0001689375-25-000035:0·
Ideal exit: 7 Feb 2025 (T+270)
2 of 2 declarations
About KIM PETER S
Kim Peter S is a Director at Entrada Therapeutics, Inc., an innovative company in the biotechnology field. As a board member, he contributes to shaping strategy and overseeing the company's performance. Peter brings valuable expertise in biotechnology, thus supporting Entrada's mission.
